| 注册
首页|期刊导航|烟台大学学报(自然科学与工程版)|基于人工智能的PLK1 PBD新型抑制剂的筛选

基于人工智能的PLK1 PBD新型抑制剂的筛选

朱艳娟 刘小倩 冯大为 王璐琪 刘钰杭 曹琳慧 芦静

烟台大学学报(自然科学与工程版)2025,Vol.38Issue(1):92-100,9.
烟台大学学报(自然科学与工程版)2025,Vol.38Issue(1):92-100,9.DOI:10.13951/j.cnki.37-1213/n.240112

基于人工智能的PLK1 PBD新型抑制剂的筛选

Screening of Novel Inhibitors of PLK1 PBD Based on Artificial Intelligence

朱艳娟 1刘小倩 1冯大为 1王璐琪 1刘钰杭 1曹琳慧 1芦静1

作者信息

  • 1. 烟台大学药学院,分子药理和药物评价教育部重点实验室(烟台大学),新型制剂与生物技术药物研究山东省高校协同创新中心,山东烟台 264005
  • 折叠

摘要

Abstract

The COVIDVS model,based on compound property prediction,and the RTMScore model,based on pro-tein-compound interaction prediction,were used for virtual screening of more than 1.4 million compounds.New small molecule inhibitors targeting PLK1 PBD were selected according to their binding patterns in binding pockets(tyrosine binding pockets and phosphopeptide-binding pockets containing H538 and K540).The inhibitory activity on HCT116 tumor cells was determined by MTT assay,and the anti-proliferation and migration ability of HCT116 tumor cells were assessed by cell cloning and cell scratch experiments.Finally,the targeting properties of the com-pounds were verified by molecular dynamics simulation and cell heat transfer analysis experiments.The results showed that 5 compounds were selected from the 2291 compounds with a COVIDVS predicted score of 1 and RTM-Score ≥80,among which compound 1 had an inhibition rate of more than 60%on HCT116 tumor cells at 10 μmol·L-1,with an IC50 of 7.24 μmol·L-1.Compound 1 inhibited the formation of HCT116 cell clones and the migration of HCT116 tumor cells.Molecular simulations showed that compound 1 could bind to the PLK1 PBD domain,which was confirmed by the cell heat transfer experiments.

关键词

PLK1/PBD结构域/小分子抑制剂/活性测试

Key words

PLK1/Polo-box domain/small-molecule inhibitor/activity assay

分类

医药卫生

引用本文复制引用

朱艳娟,刘小倩,冯大为,王璐琪,刘钰杭,曹琳慧,芦静..基于人工智能的PLK1 PBD新型抑制剂的筛选[J].烟台大学学报(自然科学与工程版),2025,38(1):92-100,9.

基金项目

泰山学者项目(主持人:赵克浩). (主持人:赵克浩)

烟台大学学报(自然科学与工程版)

1004-8820

访问量0
|
下载量0
段落导航相关论文